FDA Approved: SOMATULINE DEPOT — Original Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Somatuline Depot (lanreotide acetate) under the Original Application for Ipsen Biopharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Gastroenteropancreatic Neuroendocrine Tumors

Drugs mentioned

• SOMATULINE DEPOT (LANREOTIDE ACETATE)

Snippet

ORIG AP for SOMATULINE DEPOT (LANREOTIDE ACETATE)